Bascom Palmer News Today

A recent clinical trial, BRILLIANCE demonstrated the safety and efficacy of CRISPR gene editing in treating inherited blindness caused by mutations in the CEP290 gene.

BRILLIANCE trial results showed 11 out of 14 treated participants experienced some improvements in vision and quality of life measures. CRISPR-based therapy

Future studies must ensure the approach is safe, without serious side effects, expert says

MIAMI, Aug. 1, 2023 /PRNewswire/ -- Bascom Palmer Eye Institute of the University of Miami Health System has been ranked again as the nations bes...

Fourth fun in Bayview

Fourth fun in Bayview

Bascom Palmer’s Kendall Donaldson, MD, MS, on creating a culture of camaraderie and togetherness

/PRNewswire/ -- Felipe A. Medeiros, M.D., Ph.D., one of the worlds leading glaucoma experts, has joined Bascom Palmer Eye Institute and the University of...

One patient of the recalled eye drops has broken her silence after suffering severe eye damage.

Renee Martray of South Carolina has severe and permanent corneal scarring resulting in vision loss. She says its like trying to peer through eyeglasses that have been dipped in oil.